ArticleJCI insight2020
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target.
Stefano Pierini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled ittrialcites it